Stock Market News 27 January 2026

NAB share price jumps after holiday break as Australia CPI and RBA decision loom

National Australia Bank shares closed up 1.3% at A$42.88 Tuesday after a stronger business survey fueled rate speculation ahead of Wednesday’s inflation data. The S&P/ASX 200 rose 0.92%, led by banks and resource stocks. Investors await Australia’s December CPI on Jan. 28 and the RBA’s rate decision on Feb. 3.

27 January 2026

ASX:NAB·Inflation·Stock Market

CSL share price jumps 2% after ASX break as investors zero in on February results

CSL shares closed 2.0% higher at A$183.20 in Sydney, after reaching A$184.62 intraday. Investors are repositioning ahead of half-year results and an interim dividend on Feb. 11, focusing on plasma margins, immunoglobulin sales, and the new drug Andembry. Seqirus remains a concern after the company postponed its spin-off and cut growth forecasts in October.

27 January 2026

ASX News·ASX:CSL·Stock Market

Lynas share price slides 5% despite ASX rally as rare-earth policy bets churn

Lynas Rare Earths fell 5.0% to A$16.01 at Tuesday’s close, underperforming a rising S&P/ASX 200, which gained 0.92%. Arafura dropped 6.9% and Iluka lost 4.6%. The declines came as investors weighed new U.S. government funding for rare earths and after Lynas reported a 30% drop in December-quarter NdPr output due to outages and maintenance.

27 January 2026

ASX News·ASX:ARU·ASX:ILU·ASX:LYC·Stock Market

Fortescue shares rise after Alta Copper vote clears path to full buyout

Fortescue shares closed up 1.7% at A$21.87 after Alta Copper shareholders approved Fortescue’s acquisition offer. The deal, valuing Alta at about C$139 million, still needs court and regulatory clearance. Fortescue clarified it owns 36% of Alta Copper. Investors await the company’s half-year results on Feb. 25.

27 January 2026

ASX:FMG·Mining Industry·Stock Market

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 27.01.2026

5N Plus Inc. shares have surged over 1,200% in a decade, while Brookfield Infrastructure Partners trades near $48.35, up from $20 ten years ago. PROCEPT BioRobotics rose 3.95% in one day but remains down 57.81% year-over-year. Micron Technology posted 57% cloud revenue growth and trades at a forward P/E of 11.6. India’s Sensex jumped nearly 600 points to 82,451 on trade deal optimism.

27 January 2026

Stock Market

SLB stock price edges higher near a fresh high as banks lift targets again

SLB shares closed Monday up 1.1% at $49.70, trailing Baker Hughes’ 4.4% gain. JPMorgan and RBC raised their SLB price targets to $54 after the company’s 2026 outlook. Trading volume in SLB was well above average. U.S. officials are reportedly in talks with Chevron and oil-service firms, including SLB, about boosting Venezuelan crude output.

27 January 2026

NYSE:SLB·Stock Market

Bloom Energy stock drops as Jefferies lifts target but stays bearish ahead of Feb. 5 results

Bloom Energy shares fell 3.7% to $139.62 Monday, underperforming the S&P 500’s 0.5% gain. Jefferies raised its price target to $92 but kept an Underperform rating, warning expectations are high. Investors await Bloom’s Feb. 5 results for updates on 2026 deployments and margins. Other fuel-cell stocks, including Plug Power and FuelCell Energy, also dropped.

27 January 2026

Earnings Reports·Energy Sector·NASDAQ:BLDP·NASDAQ:FCEL·NASDAQ:PLUG·NYSE:AEP·NYSE:BE·Stock Market

RTX stock slips ahead of earnings as Airbus flags Pratt & Whitney engine bottlenecks

RTX shares fell 0.9% to $194.13 Monday ahead of its earnings report due before Tuesday’s open. Airbus flagged ongoing delivery problems with Pratt & Whitney engines, raising pressure on RTX. Options trading suggests a 5% stock move after results. Wall Street expects earnings of $1.47 per share on $22.7 billion in revenue.

27 January 2026

Aerospace Industry·Earnings Reports·NYSE:RTX·Stock Market

Intuitive Surgical stock in focus after FDA clears da Vinci 5 for heart procedures

Intuitive Surgical shares rose nearly 1% to $528.81 after U.S. regulators cleared its da Vinci 5 system for select cardiac procedures. The FDA approval covers thoracoscopic cardiac surgeries using non-force feedback tools. TD Cowen started coverage with a Buy rating and a $660 price target. About 17,000 da Vinci cardiac procedures were performed globally in 2025.

27 January 2026

NASDAQ:ISRG·Stock Market

Nebius (NBIS) stock drops 3% after wild swing as traders look to the next catalyst

Nebius Group shares fell 3.2% to $91.46 Monday, underperforming the S&P 500 and tech peers despite heavy trading and a session swing from $100.82 to $91.35. The company faces scrutiny over cash needs and expansion plans as it prepares to deploy Nvidia’s new “Rubin” platform and chases multi-billion-dollar AI infrastructure deals with Microsoft and Meta.

27 January 2026

NASDAQ:NBIS·Stock Market

Citigroup stock edges higher as harassment lawsuit hits headlines ahead of Fed meeting

Citigroup shares closed up 0.9% at $114.65 Monday, edging higher after hours despite news of a lawsuit alleging mishandled sexual harassment claims by a former managing director. The suit names Andy Sieg, head of Citi’s wealth division; Citi called the allegations “absolutely meritless.” The stock’s move tracked gains in other major banks ahead of a key Federal Reserve meeting starting Tuesday.

27 January 2026

Federal Reserve·NYSE:C·Stock Market

Starbucks stock price slips after hours as Wall Street lines up earnings and investor day (SBUX)

Starbucks shares fell 1.3% after hours Monday to $96.33. Analysts expect Q1 revenue of $9.63 billion and earnings per share of $0.57, with U.S. same-store sales seen rising 3% to 4%. The company reports earnings Jan. 28 and holds an investor day Jan. 29. A proxy filing set the annual meeting for March 25.

27 January 2026

Earnings Reports·NASDAQ:SBUX·Stock Market

Uber stock slips as NYC forces 10% tip prompt on Uber Eats orders; focus turns to Feb. 4 earnings

Uber shares fell 0.4% to $81.98 Monday after New York City’s new tipping rules for delivery apps took effect. DoorDash, Uber, and Instacart failed to block the regulations in court and plan to appeal. The rules require a tip prompt at checkout and ban hidden or delayed tipping options. Investors await Uber’s Feb. 4 earnings for signs of regulatory impact on delivery demand and costs.

27 January 2026

Earnings Reports·NASDAQ:UBER·Stock Market

Boston Scientific (BSX) stock ticks higher again — what to watch before Tuesday’s trade

Boston Scientific shares rose 1.12% to $93.55 Monday, outperforming Medtronic but lagging Abbott and Stryker. The company faces FDA scrutiny over its AXIOS GI stent after reports of injuries and deaths. Investors are focused on the $14.5 billion Penumbra acquisition, expected to close in 2026. Quarterly results are due Feb. 4.

27 January 2026

NYSE:BSX·Stock Market

Gilead (GILD) stock hits fresh 52-week high as new analyst targets and CEO sale filing land

Gilead Sciences shares closed at a 52-week high of $137.78 on Monday, up 1.36% for a fourth straight gain. CEO Daniel O’Day sold $15.6 million in stock under a pre-set plan, according to an SEC filing. BMO and UBS raised their price targets, citing momentum in HIV drugs and new coverage for Yeztugo. Trading volume exceeded normal levels as the stock outperformed major pharma peers.

27 January 2026

Biotechnology·NASDAQ:GILD·Stock Market

Bank of America stock price closes at $52 as Fed week looms for BAC

Bank of America shares closed Monday up 0.58% at $52.02, then slipped 0.04% to $52.00 in late after-hours trading. Investors are watching the Federal Reserve’s policy update Wednesday and a wave of major earnings reports, with bank stocks sensitive to changes in interest rate outlooks. The Dow rose 0.64%, S&P 500 0.50%, and Nasdaq 0.43%.

27 January 2026

Federal Reserve·NYSE:BAC·Stock Market

Cloudflare stock jumps on ‘Clawdbot’ buzz as NET closes higher

Cloudflare shares jumped 9.2% to $189.35 Monday amid heavy trading, fueled by speculation over the “Clawdbot” AI agent and a Wolfe Research report on surging AI traffic. Fastly rose 5.3% and Akamai 3.8%. Cloudflare’s next earnings are due Feb. 10, with investors focused on AI-driven demand and revenue from its Workers platform.

27 January 2026

NASDAQ:NET·Stock Market

Meta stock pops on a fresh $900 bull call as earnings near — here’s what investors are watching

Meta shares rose about 2% Monday after Rothschild & Co Redburn upgraded the stock to “buy” and raised its price target to $900 ahead of earnings. Bank of America kept its buy rating and $810 target, projecting Meta will top Q4 estimates. Investors are focusing on Meta’s 2026 AI spending guidance, with capital expenditures expected to reach $117 billion. Meta reports results after Wednesday’s close.

27 January 2026

Earnings Reports·NASDAQ:META·Stock Market

AbbVie stock price closes higher; what to watch next for ABBV ahead of Fed week and earnings

AbbVie shares closed up 0.7% at $220.77 on Monday, moving with broader Wall Street gains ahead of the Federal Reserve’s policy decision and major tech earnings. The company will report full-year and Q4 results before the market opens on Feb. 4. AbbVie recently signed a $650 million cancer drug licensing deal with RemeGen and faces investor scrutiny over its post-Humira growth strategy.

27 January 2026

Earnings Reports·NYSE:ABBV·Pharmaceuticals·Stock Market

Zoom stock jumps as Baird spots a “hidden gem” Anthropic stake worth up to $4 billion

Zoom shares rose about 11% Monday after a Baird analyst estimated the company’s early stake in Anthropic could be worth $2 billion to $4 billion if the AI startup reaches a $350 billion valuation. Zoom previously disclosed spending $51 million on private equity investments in early 2023 but has not detailed its Anthropic holdings.

27 January 2026

Artificial Intelligence·NASDAQ:ZM·Stock Market·Technology

Previous 1 … 171 172 173 174 175 … 1,174 Next

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

7 February 2026

New York, Feb 7, 2026, 17:36 EST — Market closed. Walt Disney shares rose 3.6% on Friday to close at $108.70, trimming the damage from an early-week slide as U.S. stocks snapped back into risk-on mode. (Yahoo Finance) With U.S. markets shut for the weekend, the next session opens with Disney caught between two big forces: a market that is suddenly willing to buy again, and a media business that is still being rewired in public. For Disney, that matters now because its most visible growth levers — streaming and experiences — move on sentiment as much as on the

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

7 February 2026

Novo Nordisk Class B shares closed up 5.3% at 295.50 Danish crowns in Copenhagen after Hims & Hers said it would stop offering a compounded pill version of Wegovy following U.S. regulatory warnings. The move came after Novo called the Hims product “illegal mass compounding” and threatened legal action. Shares had fallen nearly 8% Thursday after Hims launched the pill. Trading resumes Monday.

Amgen stock price hits 52-week high after Friday rally — what to watch into Monday

7 February 2026

Amgen shares rose 4.5% to close at $384.32 Friday, hitting a 52-week high. CVS Caremark will drop Amgen’s osteoporosis drug Prolia from some preferred lists starting April 1, replacing it with biosimilars. Investors are watching for further drug-pricing moves and key U.S. inflation data next week.

Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

7 February 2026

Linde plc shares fell 2.5% to $448.24 Friday after reporting Q4 sales up 6% to $8.76 billion and adjusted EPS of $4.20. The company guided 2026 adjusted EPS to $17.40–$17.90, below analyst consensus. JPMorgan downgraded the stock, while Morgan Stanley and UBS raised price targets. Linde repurchased $1.4 billion in shares in Q4 and returned $7.4 billion to shareholders in 2025.